Injectable nanoparticulate carriers have important potential applicati
ons such as site-specific drug delivery or medical imaging. Convention
al carriers, however, cannot generally be used because they are elimin
ated by the reticulo-endothelial system within seconds or minutes afte
r intravenous injection. To address these limitations, monodisperse bi
odegradable nanospheres were developed from amphiphilic copolymers com
posed of two biocompatible blocks. The nanospheres exhibited dramatica
lly increased blood circulation times and reduced liver accumulation i
n mice. Furthermore, they entrapped up to 45 percent by weight of the
drug in the dense core in a one-step procedure and could be freeze-dri
ed and easily redispersed without additives in aqueous solutions.